West Pharmaceutical Services, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.90 B

West Pharmaceutical Services, Inc. Revenue is USD 2.90 B for the Trailing 12 Months (TTM) ending March 31, 2025, a -1.12% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • West Pharmaceutical Services, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.93 B, a 1.56% change year over year.
  • West Pharmaceutical Services, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.88 B, a 0.09% change year over year.
  • West Pharmaceutical Services, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.88 B, a 23.85% change year over year.
  • West Pharmaceutical Services, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.33 B, a 23.21% change year over year.
Key Data
Date Revenue Revenue Gross Profit Operating Income